Publications by authors named "Derek T Witteman"
Purpose: To report a case of severe immune-mediated thrombocytopenia after intravitreal bevacizumab administration.
Methods: A 77-year-old man with right-sided macular degeneration received intravitreal bevacizumab. After his third treatment dose, he was hospitalized for symptomatic thrombocytopenia (platelet count of 3 k/μL) and underwent testing to determine the etiology.